Search Results for 'relapsed'
relapsed published presentations and documents on DocSlides.
The Biology of Relapsed and Refractory Multiple Myeloma
by alexa-scheidler
Topics. Current Treatment Options for Relapsed/Re...
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
Activity Faculty Scott C. Howard, MD,
by tatiana-dople
MSc. University of Tennessee College of . Health ...
Ibrutinib : First-in Class Inhibitor of BTK
by briana-ranney
Forms a specific and irreversible bond with cyste...
Improving Therapy Outcomes in Relapsed/Refractory
by celsa-spraggs
Hodgkin Lymphoma. Program Objectives. Brentuximab...
Relapsed or Relapsed/Refractory
by alexa-scheidler
5
Multiple Myeloma
SANDRA E. KURTIN, RN, MS, AOCN
How I treat relapsed childhood acute
by trish-goza
lymphoblastic leukemia. Â . Franco Locatelli, Ma...
Recurrent Follicular Lymphoma
by sherrill-nordquist
With a Short First Remission:. How Aggressive Sho...
A Phase Ib Dose Escalation Trial of SAR650984 (Anti-CD-38 mAb) in Combination with Lenalidomide and
by scoopulachanel
Myeloma. 1. Safety and Efficacy of Daratumumab wit...
SWAG Protocols update March 2024
by nehemiah176
Kate Gregory. Lead Pharmacist for SWAG Protocols �...
Pivotal Safety and Efficacy Results From TRANSCEND NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphomas
by botgreat
Lisocabtagene. . Maraleucel. in Relapsed/Refract...
CAR-T Therapy in non-Hodgkin lymphomas
by natalie
Jonathon B. Cohen, MD. Dept of . Hematology. /Medi...
Ro le of Stem Cell Transplant in Patients with Peripheral T-Cell
by sylvia
Lymphoma and Response to Treatment Strategies . IN...
x0000x0000 xAttxachexd xBottxom xBBoxx
by evans
Chimeric Antigen Receptor Tcell TherapyClinical Gu...
Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref
by willow
Meletios Dimopoulos,. 1. Hang Quach,. 2. Maria-V...
Aktuelle Therapieempfehlungen beim Multiplen
by brown
Myelom. Heinz . Gisslinger. Medizinische Universit...
AFM13 in Combination with Allogeneic Natural Killer Cells (AB-101) in Relapsed or Refractory Hodgki
by cesar673
+. Peripheral T-Cell Lymphoma: A Phase 2 Study (L...
Please note, these are the actual video-recorded
by rayfantasy
proceedings from the live CME event and may includ...
Case Discussion A 64-year old woman diagnosed with monoclonal
by faustina-dinatale
Case Discussion A 64-year old woman diagnosed wit...
Relapsed/Refractory Follicular Lymphoma Conundrums
by danika-pritchard
This program will include a discussion of off-lab...
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
Ibrutinib for Hairy Cell Leukemia
by pasty-toler
. A Brief Update of an Ongoing Trial. Jeff Jones...
Personalized Therapy in Relapsed or Refractory CLL
by kittie-lecroy
IWCLL Criteria for Treating CLL. Other Considerat...
MEK Inhibitors and their potential role in relapsed NSCLC
by debby-jeon
Ranee Mehra, MD. Fox Chase Cancer Center. Philade...
Chronic lymphocytic leukemia,
by natalia-silvester
New agents timing?. Agne Paner, MD. Assistant pro...